Systems and methods are provided for treating or preventing carbon monoxide poisoning. In particular, systems and methods are provided for a phototherapy treatment or prevention system that delivers light radiation to a patient's body to photodissociate carbon monoxide from hemoglobin.

Systems and methods are provided for treating or preventing carbon monoxide poisoning. In particular, systems and methods are provided for a phototherapy treatment or prevention system that delivers light radiation to a patient's body to photodissociate carbon monoxide from hemoglobin.

The invention describes a specific, multilayer tubular film for the manufacture of catheter devices that are usable in the most odor-neutral manner possible. The passage of substances through the film wall may be reduced or avoided by incorporating suitable barrier layers. The delivery of strong-smelling active substances and also the discharge of intensely odorous excretions or secretions may be optimized in a problem-solving manner by proportional layers of EVOH- or PVDC-based materials, for example, in the multilayer film structure. The invention combines these barrier layers with mechanically loadable carrier layers made of polyurethane (PUR), PVC, or also polyamide (PA) or PA-related material layers, for example. The invention describes, among other things, embodiments of catheters having retaining balloon components that are equipped with odor-inhibiting layer portions over the entire intracorporeal and extracorporeal surface of the catheter and that thus provide maximum protection against release of odors. The invention further describes embodiments that are manufacturable in a particularly advantageous manner, with several of the components that make up the catheter being manufactured by simultaneous forming from a single film tube blank.

The invention describes a specific, multilayer tubular film for the manufacture of catheter devices that are usable in the most odor-neutral manner possible. The passage of substances through the film wall may be reduced or avoided by incorporating suitable barrier layers. The delivery of strong-smelling active substances and also the discharge of intensely odorous excretions or secretions may be optimized in a problem-solving manner by proportional layers of EVOH- or PVDC-based materials, for example, in the multilayer film structure. The invention combines these barrier layers with mechanically loadable carrier layers made of polyurethane (PUR), PVC, or also polyamide (PA) or PA-related material layers, for example. The invention describes, among other things, embodiments of catheters having retaining balloon components that are equipped with odor-inhibiting layer portions over the entire intracorporeal and extracorporeal surface of the catheter and that thus provide maximum protection against release of odors. The invention further describes embodiments that are manufacturable in a particularly advantageous manner, with several of the components that make up the catheter being manufactured by simultaneous forming from a single film tube blank.

The present invention provides an oral device that is inserted into the mouth of a patient during sedation to minimize the risk of airway obstruction and method of use. The oral device comprises a mouthpiece. A gas inlet conduit, a gas outlet conduit, and a fluid outlet conduit are adjacent to the vestibular portion of the mouthpiece. The gas inlet conduit may be used to provide oxygen to the mouth of a patient. The gas outlet conduit may be used to remove end-tidal carbon dioxide from the mouth of a patient. The fluid outlet conduit may be used to remove fluid from the mouth of a patient. The oral device may also include a tongue stabilizer to minimize movement of the tongue. The mouthpiece may include fluid outlet ports to remove fluid from the mouth of a patient and an instrument passage to allow medical instruments to pass through the oral device.

The present invention provides an oral device that is inserted into the mouth of a patient during sedation to minimize the risk of airway obstruction and method of use. The oral device comprises a mouthpiece. A gas inlet conduit, a gas outlet conduit, and a fluid outlet conduit are adjacent to the vestibular portion of the mouthpiece. The gas inlet conduit may be used to provide oxygen to the mouth of a patient. The gas outlet conduit may be used to remove end-tidal carbon dioxide from the mouth of a patient. The fluid outlet conduit may be used to remove fluid from the mouth of a patient. The oral device may also include a tongue stabilizer to minimize movement of the tongue. The mouthpiece may include fluid outlet ports to remove fluid from the mouth of a patient and an instrument passage to allow medical instruments to pass through the oral device.

A thrombus engagement tool having a flexible shaft, a clot engagement tip, and a handle. The engagement tip may include one or more radially outwardly extending structures such as a helical thread. The helical thread can be advanced through a catheter to engage a clot. The handle may be configured to be rotated by hand. When the handle is rotated, the helical thread of the engagement tip can rotate in the same direction thereby allowing the helical threat to engage the clot. The helical thread can wrap around the flexible shaft at least about one, two, or four or more full revolutions, but in some cases no more than about ten or no more than about six revolutions.

A clot capture module can include a housing, a chamber inside the housing, a window, and a filter. The window permits visual inspection of a clot inside the chamber. The clot can access the chamber via an incoming flow path configured to direct blood from an aspiration catheter to an upstream surface of the filter. An aspiration control valve can block the flow of incoming aspirated blood until actuated to permit inflow of aspirated blood. An outgoing flow path can direct blood from a downstream surface of the filter to a remote vacuum canister.

A removable second stage biocompatible substrate filter including biocompatible implant material configured to trap second stage operative particulate matter, wherein the removable second stage biocompatible substrate filter is configured to combine with first stage operative particulate matter captured from irrigation fluid by a first stage filter, defining a combined product and the removable second stage biocompatible substrate filter is configured to be removable from a filter device container.

Embodiments of the present invention disclose a method of cosmetic or biomedical application of a device, comprising a self-contained syringe device comprising an inner syringe included within an outer syringe and wherein a filter is attached inside the outer syringe barrel; wherein the filter comprises a filter material that prevents premature filter collapse where the filter material is optionally coated to increase stiffness, and wherein liposuctioned adipose tissue is collected and purified inside the syringes.